Diseases [C] » Nervous System Diseases [C10] » Central Nervous System Diseases » Spinal Cord Diseases
Description
Pathologic conditions which feature SPINAL CORD damage or dysfunction, including disorders involving the meninges and perimeningeal spaces surrounding the spinal cord. Traumatic injuries, vascular diseases, infections, and inflammatory/autoimmune processes may affect the spinal cord. MeSH
Hierarchy View
Subtype Terms (14)
Amyotrophic Lateral Sclerosis
216 drugs (96 approved, 120 experimental)
Muscular Atrophy, Spinal
28 drugs (18 approved, 10 experimental)
Myelitis
5 drugs (4 approved, 1 experimental)
Spinal Cord Compression
5 drugs (3 approved, 2 experimental)
Spinal Cord Injuries
179 drugs (96 approved, 83 experimental)
Spinal Cord Neoplasms
15 drugs (10 approved, 5 experimental)
Spinocerebellar Degenerations
5 drugs (2 approved, 3 experimental)
Stiff-Person Syndrome
14 drugs (12 approved, 2 experimental)
Subacute Combined Degeneration
Syringomyelia
1 approved drug
Approved Indicated Drugs (3)
Phase 4 Indicated Drugs (3)
Phase 3 Indicated Drugs (4)
Organization Involved with Phase 4 Indications (8)
Organization Involved with Phase 3 Indications (18)
Organization Involved with Phase 2 Indications (9)
Organization Involved with Phase 1 Indications (2)
Organization Involved with Other Experimental Indications (4)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.